What Is MOTS-c? Dosage, Half-Life & How to Track It

What MOTS-c is and how it works

MOTS-c stands for “mitochondrial open reading frame of the 12S rRNA-c” — a mouthful that describes exactly what makes it unusual. Discovered in 2015, it’s one of a handful of known mitochondrial-derived peptides (MDPs) — small proteins encoded not in your nuclear DNA but inside mitochondrial DNA itself, in a region previously assumed to only code for structural RNA, not proteins.

Functionally, MOTS-c is a metabolic regulator that works primarily by activating AMPK (AMP-activated protein kinase) — the cell’s central energy-sensing switch, the same one that flips on during exercise and calorie restriction and shifts metabolism toward burning fat and improving insulin sensitivity. MOTS-c levels rise sharply with exercise — roughly twelve-fold in muscle tissue in animal studies — and decline with age, which has driven interest in it as a potential way to mimic some of exercise’s metabolic benefits.

It’s important to be straight about the evidence here: no completed human clinical trials exist for MOTS-c as of now. The AMPK mechanism, the exercise-response data, and the age-related decline all come from preclinical (cell and animal) research. It’s a legitimate and actively studied area of mitochondrial biology, but human-relevant dosing, safety, and efficacy data simply doesn’t exist yet in the published literature.

Typical dosing & reconstitution

MOTS-c ships lyophilized across several vial sizes and is reconstituted with bacteriostatic water. Community protocols typically start around 500 mcg once daily subcutaneously and titrate up over eight to ten weeks toward 1,000–1,500 mcg; an alternative some people use instead is two to three larger doses (3–5 mg) per week rather than a daily small one.

Reconstitution varies by vial size:

At 3.33 mg/mL, a 1,000 mcg dose is 30 units. Higher-mg vials (10, 20, even 40 mg) exist specifically so a daily dose north of 1,000 mcg doesn’t creep past what a standard insulin syringe comfortably holds — the reconstitution calculator will show exactly where that line is for your vial.

Half-life & what it means for frequency

MOTS-c’s human half-life hasn’t been formally published — as a 16-amino-acid peptide without any extending modification, it’s assumed to clear relatively quickly, which lines up with the once-daily community dosing pattern. Reconstituted vials are also notably less stable than most peptides in this library — protocols commonly call for using the mixed solution within about a week for best potency, rather than the three-to-four-week window typical elsewhere.

That shorter usable window after mixing is a practical detail worth planning around: reconstituting a bigger vial than you’ll use in a week trades convenience for potency you may not actually get to use.

What to track & common side effects

Because no completed human trials exist, the side-effect picture is thinner than for most peptides here — community reports describe it as generally well tolerated, with injection-site reactions the main complaint, but that’s anecdotal rather than trial-documented.

What’s worth tracking: the daily dose through its titration, and — since the interest here is metabolic — body composition, energy, and any glucose or insulin markers you’re already tracking elsewhere, so you have an actual before/after rather than an impression.

Frequently asked questions